IP Library Granted Patent US 11,619,637
Granted Patent B2
US 11,619,637 · App. 15/936,354 · Granted Apr 4, 2023

Biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disorders

Inventor: Edward J. Goetzl (San Francisco, CA)
Assignee: NanoSomiX, Inc.
G01N33/6896G01N2800/285G01N2800/2814G01N2800/2821G01N2800/2835G01N2800/50G01N2800/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,619,637
App. No.
15/936,354
Granted
Apr 4, 2023
Kind
B2
Abstract

The present invention relates to biomarkers and diagnostic and prognostic methods for Alzheimer's disease and other neurodegenerative disorders. The invention also provides compositions for detecting the biomarker as well as compositions and methods useful for treating Alzheimer's disease and other neurodegenerative disorders.

Claims (2)

1. A method of analyzing a sample from a subject comprising the steps of: (i) obtaining a biological sample comprising exosomes from a subject, (ii) isolating exosomes from the biological sample comprising: contacting the biological sample with an antibody under conditions wherein the exosomes present in the biological sample bind to the antibody to form an exosome-antibody complex, thereby isolating the exosomes from the sample, and (iii) detecting one or more proteins or phosphorylated proteins from the isolated exosomes with an immunoassay, wherein the biological sample is whole blood, serum, or plasma, and wherein the exosomes are selected from the group consisting of neuron-derived exosomes, astrocyte-derived exosomes, oliogodendrocyte-derived exosomes, and microglia-derived exosomes, wherein the antibody is an anti-NCAM antibody, an anti-CD171 antibody; an anti-CD9 antibody; and/or an anti-CD81 antibody.

2. The method of claim 1 , wherein the subject is selected from the group consisting of a human, a monkey, a dog, a pig, a bovine, a rabbit, a guinea pig, and a rodent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2021
From: GOETZL, EDWARD J
To: NANOSOMIX, INC.
Reel/Frame 054868/0060 →
Continuity (5)
Continuation 14522585 · Oct 24, 2014
Provisional Application 62047062 · Sep 8, 2014
Provisional Application 61978994 · Apr 14, 2014
Provisional Application 61895376 · Oct 24, 2013
Related Publication 20180217165A1 · Aug 2, 2018